Working towards better autism treatment

Mercè Pallàs

Universitat de Barcelona, Spain

Autism Spectrum Disorder affects millions of children worldwide, with challenges that last a lifetime. Current treatments often fail to address the root causes of the condition and may lead to significant side effects. This project is working on a new approach that could change lives.

The focus is on how genes are controlled in the brain, a process that plays a key role in the development of autism. Scientists have identified certain factors in the brain that influence social interaction and repetitive behaviors—two core symptoms of autism. Inspired by these findings, the team has created a new medicine that could improve how the brain works in these areas. Early studies in mice have shown promising results, with improvements in social behaviors and cognitive functions. This medicine works differently from current treatments, offering hope for fewer unwanted effects and a safer long-term option.

This medicine also builds upon discoveries from related conditions like Alzheimer's disease, demonstrating its potential to improve brain functions that affect social interactions and behaviors. Importantly, the researchers aim to address the symptoms of autism while avoiding the side effects that many current treatments cause, such as sedation or cognitive dulling. By focusing on a more precise method of action, this treatment may offer safer and more effective relief.

The next step in the project is testing this medicine further, using different animal models to ensure it works safely and effectively. If successful, this medicine could offer a groundbreaking new way of treating autism, improving the quality of life for individuals and their families.

This approach combines cutting-edge science with a deep understanding of the challenges people with autism face. By focusing on the causes of the condition, this project hopes to create a treatment that not only addresses symptoms but also improves overall well-being. With more research, this innovative method could bring hope to families affected by autism.

Preclinical development of a first-in-class treatment for autism spectrum disorder

Stage 1